Transforming Healthcare
50
Portfolio Companies
With More Than $1.9 Billion
Under Management
45
Clinical Studies
Underway Within Our Portfolio
60
Diseases
Being Targeted By
Our Companies
10
of thousands
Patients Impacted
By Portfolio Company Products
and Clinical Trials